Basel Medical Group Ltd
BMGL
$2.02
-$0.17-7.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -83.12% | -41.87% | 16.75% | -- | -- |
| Total Depreciation and Amortization | 23.47% | 9.34% | -3.73% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -235.89% | -267.89% | -385.82% | -- | -- |
| Change in Net Operating Assets | -18.22% | -42.51% | -100.79% | -- | -- |
| Cash from Operations | -188.11% | -76.52% | -2.68% | -- | -- |
| Capital Expenditure | -98.57% | -70.69% | -26.09% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 487.14% | 284.48% | -26.09% | -- | -- |
| Total Debt Issued | 153.10% | 161.37% | -- | -- | -- |
| Total Debt Repaid | -212.89% | -416.55% | 0.59% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,342.96% | 1,403.38% | 105,950.00% | -- | -- |
| Cash from Financing | 473.48% | 224.83% | 39.38% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,475.57% | 993.72% | 313.81% | -- | -- |